Madrigal Pharmaceuticals, Inc. with ticker code (MDGL) have now 12 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between 416 and 194 suggesting an average Analsyt target price of $328.67. Given that the stocks previous close was at $276.49 this would indicate that there is a potential upside of 18.9%. The 50 day MA is $268.27 and the 200 day MA is $177.38. The company has a market cap of 5.06B. The current stock price for Wyndham Hotels & Resorts, Inc. is currently 276.61 USD
The potential market cap would be $6,013,719,807 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of – and a -70.78% return on assets.
